1. Home
  2. IRWD vs EB Comparison

IRWD vs EB Comparison

Compare IRWD & EB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • EB
  • Stock Information
  • Founded
  • IRWD 1998
  • EB 2003
  • Country
  • IRWD United States
  • EB United States
  • Employees
  • IRWD N/A
  • EB N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • EB EDP Services
  • Sector
  • IRWD Health Care
  • EB Technology
  • Exchange
  • IRWD Nasdaq
  • EB Nasdaq
  • Market Cap
  • IRWD 251.8M
  • EB 226.8M
  • IPO Year
  • IRWD 2010
  • EB 2018
  • Fundamental
  • Price
  • IRWD $3.11
  • EB $2.60
  • Analyst Decision
  • IRWD Buy
  • EB Buy
  • Analyst Count
  • IRWD 5
  • EB 2
  • Target Price
  • IRWD $5.34
  • EB $5.25
  • AVG Volume (30 Days)
  • IRWD 3.2M
  • EB 656.7K
  • Earning Date
  • IRWD 11-10-2025
  • EB 11-06-2025
  • Dividend Yield
  • IRWD N/A
  • EB N/A
  • EPS Growth
  • IRWD N/A
  • EB N/A
  • EPS
  • IRWD 0.18
  • EB N/A
  • Revenue
  • IRWD $338,987,000.00
  • EB $294,798,000.00
  • Revenue This Year
  • IRWD N/A
  • EB N/A
  • Revenue Next Year
  • IRWD N/A
  • EB $9.53
  • P/E Ratio
  • IRWD $17.56
  • EB N/A
  • Revenue Growth
  • IRWD N/A
  • EB N/A
  • 52 Week Low
  • IRWD $0.53
  • EB $1.81
  • 52 Week High
  • IRWD $5.13
  • EB $4.12
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 74.04
  • EB 53.44
  • Support Level
  • IRWD $1.88
  • EB $2.13
  • Resistance Level
  • IRWD $3.47
  • EB $2.90
  • Average True Range (ATR)
  • IRWD 0.33
  • EB 0.14
  • MACD
  • IRWD 0.12
  • EB 0.03
  • Stochastic Oscillator
  • IRWD 79.56
  • EB 60.39

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About EB Eventbrite Inc.

Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.

Share on Social Networks: